bi-specific Azymatic antibody (Zymeworks)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namebi-specific Azymatic antibody (Zymeworks)

Drug Alias Namebi-specific antibody for autoimmune disease (Zymeworks)

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsAutoimmune Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanada

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesZymeworks Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesZymeworks Inc

Active IndicationsN/A

Inactive IndicationsAutoimmune Diseases

Other Information

ATC CodeN/A